Proven to provide accuracy over SPECT, Flyrcado creates more access to advanced cardiac imaging.^4-8 Explore how Flyrcado can bring cardiac PET to more people in more sites of care.
Please see full prescribing information here.

Save the date to attend Advancing cardiac PET accessibility: Implementing shared cardiac PET services with Flyrcado™ (flurpiridaz F 18) injection.

June 22, 2025 6:45 am - 7:45 am CT, New Orleans Convention Center 2nd Floor RM 06-07

Implementing a shared Myocardial Perfusion Imaging (MPI) PET/CT program, healthcare institutions can position themselves at the forefront of advanced cardiac imaging while optimizing resource utilization. Previously, however, implementing a shared program was hindered by the availability of cardiac PET tracers requiring an on-site cyclotron or generator. The introduction of Flyrcado (flurpiridaz F 18) injection now provides accessibility of a unit dose cardiac PET tracer supplied from a local CMO allowing healthcare institutions to consider implementing a shared cardiac PET program without a large upfront financial commitment. This session will provide an overview of the practical considerations and clinical value of implementing a shared cardiac PET/CT MPI program with Flyrcado.

Now, you can have both. The precision of cardiac PET over SPECT joins the flexibility enabled by Flyrcado to increase access, diagnostic accuracy, and options for your cardiac imaging team.^1-6

PET is the most effective form of MPI for detecting CAD.^1-4 Now, with Flyrcado, you gain the flexibility of the longest available half-life of any cardiac PET tracer.^1,4-6 Proven to provide accuracy over SPECT, Flyrcado creates more access to advanced cardiac imaging.⁴

GE HealthCare offers an online electronic reader training program for the proper interpretation of Flyrcado positron emission tomography (PET) myocardial perfusion imaging (MPI) images.